Skip to content
Lower risk Medical device recall · FDA · Published August 19, 2020

Siemens Dimension LOCI TNIH Flex Reagent Cartridge Recall: Positive Bias Risk

Siemens Healthcare recalls Dimension LOCI High Sensitivity Troponin I (TNI: Flex) reagent cartridges with potential positive bias in cardiac troponin I measurements, risking inaccurate test results.

🇺🇸 FDA recall #Z-0052-2021Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.500 Gbc Dr · Newark, DE 19702-2466
✎ GovInfoNow plain-language explainer

Siemens Healthcare is recalling Dimension LOCI High Sensitivity Troponin I (TNIH) Flex reagent cartridges that may give falsely high results for cardiac troponin I tests. This could lead to incorrect diagnoses of heart conditions if used in medical testing. Read more at govinfonow.com/recall/64451-siemens-dimension-loci-tnih-flex-reagent-cartridge-recall-positive-bias.

Source Summary by GovInfoNow · govinfonow.com/recall/64451-siemens-dimension-loci-tnih-flex-reagent-cartridge-recall-positive-bias · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0052-2021

Cite this page

“Siemens Dimension LOCI TNIH Flex Reagent Cartridge Recall: Positive Bias Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/64451-siemens-dimension-loci-tnih-flex-reagent-cartridge-recall-positive-bias. Based on FDA recall #Z-0052-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0052-2021%22&limit=1).

The FDA announced on Aug. 19, 2020, that Siemens Healthcare Diagnostics, Inc. is recalling Dimension LOCI High Sensitivity Troponin I (TNIH) Flex reagent cartridges due to a positive bias in test results. The agency said the defect could lead to falsely elevated troponin measurements.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: Dimension LOCI High Sensitivity Troponin I (TNIH) Flex reagent cartridge
  • Catalog Number: RF627, SMN# 10471068
  • Lot # EB0255
  • Lot # EA0178
  • UDI: 00842768037726EB025520091110471068840

The hazard

According to the FDA, the recalled lots exhibit a positive bias across the Analytical Measurement Range compared to an unaffected control lot. The agency reported an average bias of +25% in patient samples for lots EB0255 and EA0178, with a maximum bias of +34% observed around the 99th percentile.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has had 150 other recalls on record since June 7, 2017. Other recent recalls of similar products include Siemens Atellica CH RCRP Test May Give False High Results (Aug. 17, 2026), Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (July 13, 2026), and Siemens Atellica CH Urine Albumin Recall (July 6, 2026). Other recent recalls of similar products include HardyDisk AST Cefiderocol 30μg FDC30 (June 8, 2026), Menopause Test Cassette Recall (Nov. 22, 2025), and Changchun Wancheng Bio-Electron UTI Test Strips Recall (Nov. 22, 2025).

How to tell if you have this one

Check for lot numbers EB0255 or EA0178 on the cartridge packaging. The product was sold with catalog number RF627 and UDI code 00842768037726EB025520091110471068840.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Cartridge Lot Number

    Look for lot numbers EB0255 or EA0178 on the cartridge packaging to determine if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3 years after the firm started it.

1. Firm started the recall: Aug 19, 202012. FDA classified it Class II: Oct 2, 202023. Published in FDA’s Enforcement Report: Oct 14, 202034. FDA terminated the recall: Aug 25, 2023420202023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0052-2021 (August 19, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0052-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA